Germany’s Bayer said on Sunday it was starting a Phase III study program to investigate the efficacy and safety of asundexian, an oral Factor XIa (FXIa) inhibitor.
AstraZeneca’s blockbuster diabetes drug Farxiga led to significant reductions in the risk of hospitalization and death in people with all types of heart failure, according to study data released on Saturday, opening the door to a substantial increase in patients who could benefit.
Abbott Laboratories has restarted production of its Similac infant formula at the plant in Sturgis, Michigan at the center of the U.S. baby formula shortage.
Most doses of Bavarian Nordic’s two-dose Jynneos monkeypox vaccine administered in the United States have been first doses, U.S. Centers for Disease Control and Prevention Director Rochelle Walensky said on Friday.
Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic.
The report summarizes various measures of the pharmaceutical industry’s ability to deliver quality drugs to U.S. patients and consumers.
In a Securities and Exchange Commission report filed Thursday, Zymergen revealed it is cutting 80 more jobs and parting ways with Zach Serber, its co-founder and chief scientific officer, on Sept. 22.
Merck’s bid to buy the cancer-focused Seagen has hit a roadblock after the two companies failed to agree on a price, according to a Bloomberg report published Friday, citing sources familiar with the matter.
Britain’s medicines regulator on Friday approved Novavax’s COVID-19 vaccine for children aged between 12 and 17 years.
ReutersThe E.coli bacteria outbreak in four Midwest states from an unknown source has affected 47 more people, the U.S. Centers for Disease Control and Prevention said on Thursday, with a majority of the total 84 reported to have sandwiches at Wendy’s.
